| dc.contributor.author | Başçı, Semih | |
| dc.contributor.author | Yigenoğlu, Tuğçe Nur | |
| dc.contributor.author | Dal, Mehmet Sinan | |
| dc.contributor.author | Korkmaz, Serdal | |
| dc.contributor.author | Turgut, Burhan | |
| dc.contributor.author | Altuntaş, Fevzi | |
| dc.date.accessioned | 2022-05-11T14:39:59Z | |
| dc.date.available | 2022-05-11T14:39:59Z | |
| dc.date.issued | 2020 | |
| dc.identifier.issn | 1078-1552 | |
| dc.identifier.issn | 1477-092X | |
| dc.identifier.uri | https://doi.org/10.1177/1078155220967081 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.11776/8822 | |
| dc.description.abstract | [No Abstract Available] | en_US |
| dc.language.iso | eng | en_US |
| dc.publisher | Sage Publications Ltd | en_US |
| dc.identifier.doi | 10.1177/1078155220967081 | |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.title | Tyrosine kinase inhibitors and COVID-19 | en_US |
| dc.type | letter | en_US |
| dc.relation.ispartof | Journal of Oncology Pharmacy Practice | en_US |
| dc.department | Fakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalı | en_US |
| dc.authorid | 0000-0001-9962-8882 | |
| dc.authorid | 0000-0003-4304-9245 | |
| dc.identifier.volume | 26 | en_US |
| dc.identifier.issue | 8 | en_US |
| dc.identifier.startpage | 2072 | en_US |
| dc.identifier.endpage | 2073 | en_US |
| dc.institutionauthor | Burhan, Turgut | |
| dc.relation.publicationcategory | Diğer | en_US |
| dc.authorscopusid | 56545735000 | |
| dc.authorscopusid | 57219552804 | |
| dc.authorscopusid | 57219550186 | |
| dc.authorscopusid | 56493217400 | |
| dc.authorscopusid | 57219547378 | |
| dc.authorscopusid | 57219552831 | |
| dc.authorwosid | Yigenoglu, Tugce/ABF-6595-2021 | |
| dc.authorwosid | Başcı, Semih/AAB-4823-2021 | |
| dc.identifier.wos | WOS:000583673900001 | en_US |
| dc.identifier.scopus | 2-s2.0-85093832489 | en_US |
| dc.identifier.pmid | 33081581 | en_US |
